Biodel to Report Fourth Quarter and Fiscal Year 2015 Financial Results on December 17, 2015

DANBURY, CT -- (Marketwired) -- 12/14/15 -- Biodel Inc. (NASDAQ: BIOD) will issue its fourth quarter fiscal year 2015 financial results on Thursday, December 17, 2015. Following the release of the company's financial results, Biodel's senior management will host a conference call to discuss the results and provide an update on the company's progress.

December 17, 2015 schedule:

4:00 pm EST: Fourth quarter fiscal year 2015 results will be distributed

4:45 pm EST: Conference call participants should dial:
+1 (877) 407-7181 (United States & Canada) or
+1 (201) 689-8047 (International)

5:00 pm EST: Conference call begins

Interested parties may access a live audio webcast of the conference call in the investor section of Biodel's website at www.biodel.com. The audio webcast will be archived and available for replay through the website.

About Biodel Inc.
Biodel Inc. is a specialty biopharmaceutical company focused on the development and commercialization of innovative treatments for diabetes that may be safer, more effective and more convenient for patients. Biodel's product candidates are developed by applying proprietary technologies to existing drugs in order to improve their therapeutic profiles. More information about Biodel is available at www.biodel.com.

BIOD-G

   CONTACT: Clayton Robertson+1 (646) 378 2964

Source: Biodel, Inc.

You May Also Be Interested In

• St. Joe Company (JOE) Reports Q1 EPS of $0.24
• ESSA Bancorp (ESSA) Tops Q2 EPS by 13c
• Core Laboratories (CLB) Misses Q1 EPS by 13c